Is Canopy Growth a Buy for Its Pet CBD?
In a period when people are spending more time at home, they are also spending a lot more time with their pets. And with more time to connect with furry coworkers, people are becoming more atune to their pets' behaviors and health needs. This is where cannabidiol (CBD) comes in. CBD, the second most prevalent active ingredient in cannabis (after tetrahydrocannabinol, or THC), is earning attention as a potential treatment for many of man's best friend's problems, including anxiety, arthritis, and pain.
Earlier this year, Canopy Growth Corporation (NASDAQ: CGC) began offering CBD oils and soft chews that can help calm your pet's behavior and treat other health conditions. But does the revolutionary product make the stock a buy?
Image Source: Getty Images
Source Fool.com
